1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Oncology Biosimilars Industry 2015 Market Research Report

Global Oncology Biosimilars Industry 2015 Market Research Report

  • August 2015
  • -
  • QY Research Group
  • -
  • 212 pages

Summary


The Global Oncology Biosimilars Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oncology Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Oncology Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Oncology Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 215 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Oncology Biosimilars Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
1.3 Applications of Oncology Biosimilars
1.4 Industry Chain Structure of Oncology Biosimilars
1.5 Industry Regional Overview of Oncology Biosimilars
1.6 Industry Policy Analysis of Oncology Biosimilars
1.7 Industry News Analysis of Oncology Biosimilars

2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.1 Raw Material Suppliers and Price Analysis of Oncology Biosimilars
2.2 Equipment Suppliers and Price Analysis of Oncology Biosimilars
2.3 Labor Cost Analysis of Oncology Biosimilars
2.4 Other Costs Analysis of Oncology Biosimilars
2.5 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.6 Manufacturing Process Analysis of Oncology Biosimilars

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Oncology Biosimilars Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Oncology Biosimilars Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Oncology Biosimilars Key Manufacturers in 2014

4 Production Analysis of Oncology Biosimilars by Regions, Technology, and Applications
4.1 Global Production of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Oncology Biosimilars by Technology 2010-2015
4.3 Global Production of Oncology Biosimilars by Applications 2010-2015
4.4 Price Analysis of Global Oncology Biosimilars Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Oncology Biosimilars 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Oncology Biosimilars 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Oncology Biosimilars 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Oncology Biosimilars 2010-2015
4.9 US Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015
4.10 EU Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015
4.12 China Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015

5 Sales and Revenue Analysis of Oncology Biosimilars by Regions
5.1 Global Sales of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Oncology Biosimilars Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Oncology Biosimilars 2010-2015

6 Analysis of Oncology Biosimilars Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Oncology Biosimilars 2010-2015
6.2 Production Market Share Analysis of Oncology Biosimilars 2010-2015
6.3 Sales Overview of Oncology Biosimilars 2010-2015
6.4 Supply, Sales and Shortage of Oncology Biosimilars 2010-2015
6.5 Import, Export and Consumption of Oncology Biosimilars 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Oncology Biosimilars 2010-2015

7 Analysis of Oncology Biosimilars Industry Key Manufacturers
7.1 Biocon
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Celltrion
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Dr. Reddy's Laboratories
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Hospira
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Mylan
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Sandoz
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 3SBio
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Abbvie
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 AstraZeneca
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 BioXpress Therapeutics
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Boehringer Ingelheim
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Coherus Biosciences
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Intas Pharmaceuticals
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Merck Serono
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Pfizer
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Wockhardt
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Oncology Biosimilars Product Types
8.5 Market Share Analysis of Different Oncology Biosimilars Price Levels
8.6 Gross Margin Analysis of Different Oncology Biosimilars Applications

9 Marketing Trader or Distributor Analysis of Oncology Biosimilars
9.1 Marketing Channels Status of Oncology Biosimilars
9.2 Traders or Distributors of Oncology Biosimilars with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Oncology Biosimilars
9.4 Regional Import, Export and Trade Analysis of Oncology Biosimilars

10 Development Trend of Oncology Biosimilars Industry 2015-2020
10.1 Capacity and Production Overview of Oncology Biosimilars 2015-2020
10.2 Production Market Share Analysis of Oncology Biosimilars 2015-2020
10.3 Sales Overview of Oncology Biosimilars 2015-2020
10.4 Supply, Sales, and Shortage of Oncology Biosimilars 2015-2020
10.5 Import, Export and Consumption of Oncology Biosimilars 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Oncology Biosimilars 2015-2020

11 Industry Chain Suppliers of Oncology Biosimilars with Contact Information
11.1 Major Raw Materials Suppliers of Oncology Biosimilars with Contact Information
11.2 Manufacturing Equipment Suppliers of Oncology Biosimilars with Contact Information
11.3 Major Suppliers of Oncology Biosimilars with Contact Information
11.4 Key Consumers of Oncology Biosimilars with Contact Information
11.5 Supply Chain Relationship Analysis of Oncology Biosimilars

12 New Project Investment Feasibility Analysis of Oncology Biosimilars
12.1 New Project SWOT Analysis of Oncology Biosimilars
12.2 New Project Investment Feasibility Analysis of Oncology Biosimilars

13 Conclusion of the Global Oncology Biosimilars Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Oncology Biosimilars
Table Product Specifications of Oncology Biosimilars
Figure Global Sales Market Share of Oncology Biosimilars by Product Types in 2014
Figure Global Sales Market Share of Oncology Biosimilars by Applications in 2014
Figure Industry Chain Structure of Oncology Biosimilars
Table Global Major Oncology Biosimilars Manufacturers
Table Industry Policy of Oncology Biosimilars
Table Industry News List of Oncology Biosimilars
Table Manufacturing Cost Structure Analysis of Oncology Biosimilars in 2014
Figure Manufacturing Process Analysis of Oncology Biosimilars
Table Capacity (K Person-portion) and Commercial Production Date of Global Oncology Biosimilars Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Oncology Biosimilars Manufacturers in 2014
Table RandD Status and Technology Source of Global Oncology Biosimilars Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Oncology Biosimilars Key Manufacturers in 2014
Table Global Production of Oncology Biosimilars by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2010
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2011
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2012
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2013
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2014
Figure Global Production Market Share of Oncology Biosimilars by Regions in 2015
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2010
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2011
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2012
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2013
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2014
Figure Global Production Market Share of Oncology Biosimilars by Technology in 2015
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2010
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2011
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2012
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2013
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2014
Figure Global Production Market Share of Oncology Biosimilars by Applications in 2015
Figure Price Comparison of Global Oncology Biosimilars Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Oncology Biosimilars 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Oncology Biosimilars 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Oncology Biosimilars 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Oncology Biosimilars 2010-2015
Table US Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Global Sales of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Oncology Biosimilars by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Oncology Biosimilars by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Oncology Biosimilars 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Oncology Biosimilars 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Oncology Biosimilars 2010-2015
Table Global and Major Manufacturers Capacity of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Oncology Biosimilars Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Oncology Biosimilars Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Oncology Biosimilars 2010-2015
Figure Global Capacity Utilization Rate of Oncology Biosimilars 2010-2015
Table Global and Major Manufacturers Revenue of Oncology Biosimilars 2010-2015 (M USD)
Table Global Revenue Market Share of Major Oncology Biosimilars Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Oncology Biosimilars 2010-2015
Table China and Major Manufacturers Capacity of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Oncology Biosimilars Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Oncology Biosimilars 2010-2015
Figure China Capacity Utilization Rate of Oncology Biosimilars 2010-2015
Table China and Major Manufacturers Revenue of Oncology Biosimilars 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Oncology Biosimilars 2010-2015
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2010
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2011
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2012
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2013
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2014
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2015
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2010
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2011
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2012
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2013
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2014
Figure China Production Market Share of Major Oncology Biosimilars Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Oncology Biosimilars 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Oncology Biosimilars 2010-2015
Table Global Supply, Sales and Shortage of Oncology Biosimilars 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Oncology Biosimilars 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Oncology Biosimilars 2010-2015 (K Person-portion)
Table Price of Global Oncology Biosimilars Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Oncology Biosimilars Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Oncology Biosimilars Major Manufacturers 2010-2015
Figure Gross Margin of Global Oncology Biosimilars Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Oncology Biosimilars 2010-2015 (M USD)
Table Global Revenue Market Share of Major Oncology Biosimilars Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Oncology Biosimilars Manufacturers in 2011
Figure Global Revenue Market Share of Major Oncology Biosimilars Manufacturers in 2012
Figure Global Revenue Market Share of Major Oncology Biosimilars Manufacturers in 2013
Figure Global Revenue Market Share of Major Oncology Biosimilars Manufacturers in 2014
Figure Global Revenue Market Share of Major Oncology Biosimilars Manufacturers in 2015
Table China and Major Manufacturers of Oncology Biosimilars 2010-2015 (M USD)
Table Revenue Market Share of China Oncology Biosimilars Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Oncology Biosimilars 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Oncology Biosimilars 2010-2015
Figure Biocon Oncology Biosimilars Product Picture
Table Biocon Oncology Biosimilars Product Specification
Table 2010-2015 Biocon Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Biocon Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Biocon Oncology Biosimilars Product Production Global Market Share
Figure Celltrion Oncology Biosimilars Product Picture
Table Celltrion Oncology Biosimilars Product Specification
Table 2010-2015 Celltrion Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celltrion Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celltrion Oncology Biosimilars Product Production Global Market Share
Figure Dr. Reddy's Laboratories Oncology Biosimilars Product Picture
Table Dr. Reddy's Laboratories Oncology Biosimilars Product Specification
Table 2010-2015 Dr. Reddy's Laboratories Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Dr. Reddy's Laboratories Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Dr. Reddy's Laboratories Oncology Biosimilars Product Production Global Market Share
Figure Hospira Oncology Biosimilars Product Picture
Table Hospira Oncology Biosimilars Product Specification
Table 2010-2015 Hospira Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Hospira Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Hospira Oncology Biosimilars Product Production Global Market Share
Figure Mylan Oncology Biosimilars Product Picture
Table Mylan Oncology Biosimilars Product Specification
Table 2010-2015 Mylan Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Mylan Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Mylan Oncology Biosimilars Product Production Global Market Share
Figure Sandoz Oncology Biosimilars Product Picture
Table Sandoz Oncology Biosimilars Product Specification
Table 2010-2015 Sandoz Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Sandoz Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Sandoz Oncology Biosimilars Product Production Global Market Share
Figure 3SBio Oncology Biosimilars Product Picture
Table 3SBio Oncology Biosimilars Product Specification
Table 2010-2015 3SBio Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 3SBio Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 3SBio Oncology Biosimilars Product Production Global Market Share
Figure Abbvie Oncology Biosimilars Product Picture
Table Abbvie Oncology Biosimilars Product Specification
Table 2010-2015 Abbvie Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Abbvie Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Abbvie Oncology Biosimilars Product Production Global Market Share
Figure AstraZeneca Oncology Biosimilars Product Picture
Table AstraZeneca Oncology Biosimilars Product Specification
Table 2010-2015 AstraZeneca Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 AstraZeneca Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 AstraZeneca Oncology Biosimilars Product Production Global Market Share
Figure BioXpress Therapeutics Oncology Biosimilars Product Picture
Table BioXpress Therapeutics Oncology Biosimilars Product Specification
Table 2010-2015 BioXpress Therapeutics Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 BioXpress Therapeutics Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 BioXpress Therapeutics Oncology Biosimilars Product Production Global Market Share
Figure Boehringer Ingelheim Oncology Biosimilars Product Picture
Table Boehringer Ingelheim Oncology Biosimilars Product Specification
Table 2010-2015 Boehringer Ingelheim Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Boehringer Ingelheim Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Boehringer Ingelheim Oncology Biosimilars Product Production Global Market Share
Figure Coherus Biosciences Oncology Biosimilars Product Picture
Table Coherus Biosciences Oncology Biosimilars Product Specification
Table 2010-2015 Coherus Biosciences Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Coherus Biosciences Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Coherus Biosciences Oncology Biosimilars Product Production Global Market Share
Figure Intas Pharmaceuticals Oncology Biosimilars Product Picture
Table Intas Pharmaceuticals Oncology Biosimilars Product Specification
Table 2010-2015 Intas Pharmaceuticals Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Intas Pharmaceuticals Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Intas Pharmaceuticals Oncology Biosimilars Product Production Global Market Share
Figure Merck Serono Oncology Biosimilars Product Picture
Table Merck Serono Oncology Biosimilars Product Specification
Table 2010-2015 Merck Serono Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Merck Serono Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Merck Serono Oncology Biosimilars Product Production Global Market Share
Figure Pfizer Oncology Biosimilars Product Picture
Table Pfizer Oncology Biosimilars Product Specification
Table 2010-2015 Pfizer Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pfizer Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Pfizer Oncology Biosimilars Product Production Global Market Share
Figure Wockhardt Oncology Biosimilars Product Picture
Table Wockhardt Oncology Biosimilars Product Specification
Table 2010-2015 Wockhardt Oncology Biosimilars Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Wockhardt Oncology Biosimilars Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Wockhardt Oncology Biosimilars Product Production Global Market Share
Table Gross Margin of Global Regions 2010-2015
Table Price Comparison of Oncology Biosimilars by Regions 2010-2015 (USD/Person-portion)
Table Price of Different Oncology Biosimilars Product Types (USD/Person-portion)
Table Market Share of Different Oncology Biosimilars Price Level
Table Gross Margin of Different Oncology Biosimilars Applications
Table Traders or Distributors of Oncology Biosimilars with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Oncology Biosimilars (USD/Person-portion)
Table Regional Import, Export, and Trade of Oncology Biosimilars (K Person-portion)
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Oncology Biosimilars 2015-2020
Figure Global Capacity Utilization Rate of Oncology Biosimilars 2015-2020
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Oncology Biosimilars 2015-2020
Figure China Capacity Utilization Rate of Oncology Biosimilars 2015-2020
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2015
Figure Global Production Market Share of Major Oncology Biosimilars Manufacturers in 2020
Figure Production Market Share of China Major Oncology Biosimilars Manufacturers in 2015
Figure Production Market Share of China Major Oncology Biosimilars Manufacturers in 2020
Figure Global and China Sales (K Person-portion) and Growth Rate of Oncology Biosimilars 2015-2020
Table Global Supply, Sales and Shortage of Oncology Biosimilars 2015-2020 (K Person-portion)
Table China Supply, Sales and Shortage of Oncology Biosimilars 2015-2020 (K Person-portion)
Table China Production, Import, Export and Consumption of Oncology Biosimilars 2015-2020 (K Person-portion)
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Oncology Biosimilars 2015-2020
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Oncology Biosimilars 2015-2020
Table Major Raw Materials Suppliers of Oncology Biosimilars with Contact Information
Table Manufacturing Equipment Suppliers of Oncology Biosimilars with Contact Information
Table Major Suppliers of Oncology Biosimilars with Contact Information
Table Key Consumers of Oncology Biosimilars with Contact Information
Figure Supply Chain Relationship Analysis of Oncology Biosimilars
Table New Project SWOT Analysis of Oncology Biosimilars
Table New Project Investment Feasibility Analysis of Oncology Biosimilars
Table Part of Interviews

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.